As of November 6, 2026, Sunshine Biopharma Inc. is a publicly traded company (Nasdaq: SBFM); its largest reported holder is Mitchell P. Kopin, with 9.99% on Schedule 13G/A of August 13, 2026, then CVI Investments, Inc. (9.9%). The largest insider holding is David Natan, a director, with 68,300 shares (1.8% of shares outstanding), per Form 4 of August 11, 2026 (Schedule 13G/A, August 13, 2026).
Is this your company?
About to sign with, pay or invest in Sunshine Biopharma Inc.? See the free Snapshot first.
Free to see. No signup.
Is Sunshine Biopharma Inc. a real, registered company?
- Sunshine Biopharma Inc. files with the SEC under CIK 1402328 (its SEC filings).
- Its shares are listed under the ticker SBFM on Nasdaq (also SBFMW) (SEC company record).
- Incorporated in Colorado; business address in Fort Lauderdale, Florida, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Sunshine Biopharma, Inc in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BJI Financial Group (filed 2026-10-14).
Who are Sunshine Biopharma Inc.'s owners and officers?
Sunshine Biopharma Inc.: incorporated in Colorado; business address in Fort Lauderdale, Florida; industry Pharmaceutical Preparations (Schedule 13G, 2026-10-14).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2023-05-17)
- : Executive Officer, Director (Form D, 2023-05-17)
- : Executive Officer (Form D, 2023-05-17)
- : Director (Form D, 2023-05-17)
- : Director (Form D, 2023-05-17)
- : Director (Form D, 2023-05-17)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-14 | Bji Financial Group | 6% |
| Schedule 13G, 2026-10-13 | Cvi Investments, Inc. | 9.9% |
| Schedule 13G/A, 2026-10-05 | Alta Partners LLC | 4.9% |
| Schedule 13G/A, 2026-08-14 | L1 Capital Global Opportunities Master Fund, LTD. | 4.99% |
| Schedule 13G/A, 2026-08-13 | Mitchell P. Kopin | 9.99% |
| Schedule 13G, 2026-07-08 | Alta Partners LLC | 8.6% |
| Schedule 13G, 2026-05-22 | L1 Capital Global Opportunities Master Fund, LTD. | 5.83% |
| Schedule 13G, 2026-05-21 | Bigger Michael | 9.47% |
| Schedule 13G/A, 2025-08-14 | Altium Capital Management LLC | 0% |
Questions about who owns Sunshine Biopharma Inc.
Who owns Sunshine Biopharma Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Sunshine Biopharma Inc.: Mitchell P. Kopin (9.99%, Schedule 13G/A, filed 2026-08-13), Cvi Investments, Inc. (9.9%, Schedule 13G, filed 2026-10-13), Bigger Michael (9.47%, Schedule 13G, filed 2026-05-21) and Bji Financial Group (6%, Schedule 13G, filed 2026-10-14).
Who are the largest shareholders of Sunshine Biopharma Inc.?
By the share each holder's latest filing reports, the largest holders of Sunshine Biopharma Inc. on this page are Mitchell P. Kopin (9.99%), Cvi Investments, Inc. (9.9%) and Bigger Michael (9.47%).
When did Mitchell P. Kopin buy into Sunshine Biopharma Inc.?
The filings give report dates, not purchase dates. The earliest filing from Mitchell P. Kopin on this page is the Schedule 13G/A, filed 2026-08-13, reporting 9.99%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Sunshine Biopharma Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Sunshine Biopharma Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sunshine Biopharma Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Sunshine Biopharma Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 68,300 shares (1.8% of shares outstanding) (Form 4, 2026-08-11).
- , the chief commercial officer: 1 shares (0.00% of shares outstanding) (Form 3, 2025-01-21).
Shares outstanding: 3,877,337 as of 2026-08-13, from the company's latest SEC cover page.
How much has Sunshine Biopharma Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2023-05-17 | $5M | $5M |
Latest IPO step: Sunshine Biopharma Inc. filed its final IPO prospectus, ticker SBFM (424B4, 2026-10-09).
IPO filings: 424B4, 2026-10-09, S-1, 2026-10-02, S-1, 2026-08-28, 424B4, 2026-05-19, S-1, 2026-05-12; ticker SBFM on Nasdaq Capital Market.
Keep reading
More on Sunshine Biopharma Inc. and the records around it.
Sunshine Biopharma Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- Altium Capital Management LLC also filed stake reports on 5 other companies: Expion360 Inc. (Nov 2025), Femto Technologies Inc (Aug 2025), LogicMark, Inc. (Aug 2025)
- BIGGER CAPITAL FUND L P also filed stake reports on 13 other companies: ClearPoint Neuro, Inc. (Nov 2026), Dermata Therapeutics, Inc. (Nov 2026), BTC Digital Ltd. (Oct 2026)
- Alta Partners LLC also filed stake reports on 26 other companies: Robin Energy Ltd. (Oct 2026), Huachen AI Parking Management Technology Holding Co., Ltd (Oct 2026), C3is Inc. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/sunshine-biopharma